<DOC>
	<DOCNO>NCT00006275</DOCNO>
	<brief_summary>OBJECTIVES : I . Determine therapeutic efficacy safety topical calcitriol child psoriasis .</brief_summary>
	<brief_title>Study Topical Calcitriol Children With Psoriasis</brief_title>
	<detailed_description>PROTOCOL OUTLINE : Patients apply topical calcitriol petrolatum psoriatic lesion daily . Patients also apply petrolatum without calcitriol another psoriatic lesion daily . Patients lesion photograph prior therapy , monthly therapy , completion therapy . Lesions assess weekly 1 month every 2 week study . Blood sample collect every 1 2 month urine sample collect every 2 week study .</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis psoriasis At least 2 lesion area least 3050 cm2 Prior/Concurrent Therapy No concurrent therapy psoriasis No concurrent calcium supplement great 1,000 mg/day No concurrent prednisone drug affect serum urine calcium level Patient Characteristics Renal : No high blood urinary calcium level Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2000</verification_date>
	<keyword>dermatologic disorder</keyword>
	<keyword>psoriasis</keyword>
	<keyword>rare disease</keyword>
</DOC>